Sun, Aug 31, 2014, 6:00 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

  • ktsven ktsven Oct 11, 2013 8:16 PM Flag

    This study too late for FDA Briefing docs?

    The recent Harvard/MIT study that concluded below came out so recently so probably too late for documents but is the newest study on the subject and goes directly towards what FDA is questioning

    The researchers suggests that, even as the exact causal mechanisms are worked out, targeting triglycerides for treatment may be an effective strategy for reducing heart disease risk.

    “Clinically speaking, one of the ways to prevent a first heart attack or to reduce the risk of a second heart attack in someone who already has heart disease may be to treat patients with medicines that lower the levels of triglyceride-rich lipoproteins,” Katherisan said. “Some drugs that target triglycerides are already being tested; it is now a matter of finding the right mechanism of lowering triglycerides that will effectively reduce disease risk.”

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AMRN
1.93+0.01(+0.52%)Aug 29 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.